About this trial
This study is following a large group of people with acute hepatitis C virus (HCV) to examine why some people naturally clear the virus and some don't. It will also monitor how many people become re-infected after clearing HCV and look into why this happened.
Three months into the study, everyone taking part has the option to undergo a six month course of pegylated interferon alfa 2a (plus ribavirin for those coinfected with HIV) as treatment for their hepatitis C. The purpose of this part of the study is to examine whether treatment is effective in clearing HCV.
| Official title: | Australian Trial in Acute Hepatitis C |
|---|---|
| What is this trial studying? | Existing drug |
| Start date: | July 2004 This may be the proposed or expected start date for trials which have not yet started. |
| How many participants will this trial enrol? | 240 The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic. |
| How long is this trial planned to go for? | Participants in this trial will be asked to take the trial drug for 6 months. Following the conclusion of the trial, participants will be followed up for a further 60 months. |
| Who can enrol in this trial? | You may be eligible to participate in this trial if you meet the following criteria:
|
| Links to further information: | |
| Can I access this treatment other than by enrolling in this trial? | Pegylated interferon alpha 2a and ribavirin are PBS approved drugs. |
| Keywords: | coinfection, hepatitis C, interferon, liver, ribavirin |
While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.
- Before making the decision to participate in any clinical research, read our background information.
- Email NAPWA if you have any questions or comments about this trial
- Call the Treataware info line if you need further advice
If you've ever participated in a clinical trial, or tried to make sense of scientific research reports, you may have found some of the specialised language confusing to say the least. This Backgrounder (from the Nov-Dec 2002 edition of Positive Living) looks at the vocabulary of clinical trials.